Bobae Kim's most recent trade in Bellerophon Therapeutics Inc was a trade of 50,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Bobae Kim | VP Reg. Affairs & Quality | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 50,000 | 50,000 | - | - | Stock Options (Right to Buy) | |
| Bellerophon Therapeutics Inc | Bobae Kim | VP Reg. Affairs & Quality | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 18 May 2023 | 9,455 | 1,723 (0%) | 0% | 10 | 94,550 | Common Stock |
| Bellerophon Therapeutics Inc | Bobae Kim | VP Reg. Affairs & Quality | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.50 per share. | 18 May 2023 | 1,022 | 1,723 (0%) | 0% | 7.5 | 7,665 | Common Stock |
| Bellerophon Therapeutics Inc | Bobae Kim | VP Reg. Affairs & Quality | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 1,022 | 144 | - | - | Stock Options (Right to Buy) | |
| Bellerophon Therapeutics Inc | Bobae Kim | VP Reg. Affairs & Quality | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 266 | 0 | - | - | Stock Options (Right to Buy) | |
| Bellerophon Therapeutics Inc | Bobae Kim | VP Reg. Affairs & Quality | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.35 per share. | 18 May 2023 | 266 | 1,723 (0%) | 0% | 7.3 | 1,955 | Common Stock |